Compass Oncology — Portland, Oregon

Compass Oncology is a clinical research site located in Portland, Oregon, United States 97225.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Compass Oncology has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors, Metastatic Castration-resistant Prostate Neoplasms, B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion.

Sponsors: Hoffmann-La Roche, Janssen Research & Development, LLC, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology?

Compass Oncology has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology conducted?

Compass Oncology has 3 clinical trials on record, with 1 currently active. Their work covers Solid Tumors, Metastatic Castration-resistant Prostate Neoplasms, B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion.

Is Compass Oncology accredited by Crixeo Health?

Compass Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.